Conjunctival malt lymphoma successfully treated with single agent rituximab therapy

Leukemia Research

Volumn 33, Issue 3, 2009, Pages

  Salepci, Taflan ^a   Seker, Mesut ^a   Kurnaz, Ekrem ^a   Guler, Derya Oztas ^a   Bilici, Ahmet ^a   Dane, Faysal ^b   Aliustaoglu, Mehmet ^c   Atesoglu, Elif Birtas ^a   Gumus, Mahmut ^a   Yaylaci, Mustafa ^a  

^a Dr Lutfi Kirdar Education and Research Hospital   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c HAYDARPASA NUMUNE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ADULT; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONJUCTIVAL MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; CONJUNCTIVAL BIOPSY; EYE EXAMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; ANTIBODIES, MONOCLONAL; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; REMISSION INDUCTION;

EID: 58449127482     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.05.018     Document Type: Letter

References (14)

1. Lambo M.J., Brady L.W., and Shields C.L. Lymphoid tumors of the orbit. In: Alberti W.E., and Sagerman R.H. (Eds). Radiotherapy of intraocular and orbital tumors (1993), Springer-Verlag, Berlin, Germany 205-216
2. Fitzpatrick P.J., and Macko S. Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Phys 10 (1984) 333-340
3. Knop N., and Knop E. Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 41 (2000) 1270-1279
4. Wotherspoon A.C., Diss T.C., Pan L.X., Schmid C., Kerr-Muir M.G., Lea S.H., et al. Primary low-grade B-cell lymphoma of the conjunctiva: a mucosa-associated lymphoid tissue type lymphoma. Histopathology 23 (1993) 417-424
5. Auw-Haedrich C., Coupland S.E., Kapp A., Schmitt-Gräff A., Buchen R., and Witschel H. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Br J Ophthalmol 85 (2001) 63-69
6. Kimby E. Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 31 (2005) 456-473
7. Nückel H., Meller D., Steuhl K.P., and Dührsen U. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 73 (2004) 258-262
8. Sasai K., Yamabe H., and Dodo Y. Non-Hodgkin's lymphoma of the ocular adnexa. Acta Oncol 40 (2001) 485-490
9. Decaudin D., de Cremoux P., Vincent-Salomon A., Dendale R., and Rouic L.L. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 108 (2006) 1451-1460
10. Kobayashi A., Takahira M., Yamada A., Segawa Y., Tanahashi T., Shirao Y., et al. Fornix and conjunctiva reconstruction by amniotic membrane in a patient with conjunctival mucosa-associated lymphoid tissue lymphoma. Jpn J Ophthalmol 46 (2002) 346-348
11. Ferreri A.J., Ponzoni M., Martinelli G., Muti G., Guidoboni M., Dolcetti R., et al. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa. Haematologica 90 (2005) 1578-1579
12. Benabid L., Desablens B., Defossez T., Malthieu D., Milazzo S., and Turut P. New treatment for orbital non-Hodgkin's lymphoma: 2 cases treated with rituximab. J Fr Ophtalmol 28 (2005) 769-771 (French)
13. Sullivan T.J., Grimes D., and Bunce I. Monoclonal antibody treatment of orbital lymphoma. Ophthal Plast Reconstr Surg 20 (2004) 103-106
14. Piro L.D., White C.A., Grillo-López A.J., Janakiraman N., Saven A., Beck T.M., et al. Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol 10 (1999) 655-661